Skip to main content
SpringerLink
Log in

Pharmacokinetics and safety of a novel anti-HBs-enriched immunoglobulin in healthy volunteers after subcutaneous and intramuscular administration

  • Pharmacokinetics and Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Biotest AG (2004) Hepatect SC/IM. Investigator’s brochure. Biotest AG, Dreieich, Germany

  2. Burbach GJ, Bienzle U, Neuhaus R, Hopf U, Metzger WG, Pratschke J, Neuhaus P (1997) Intravenous or intamuscular anti-HBs immunoglobulin for the prevention of hepatitis B re-infection after orthotopic liver transplantation. Transplantation 63:478–480

    Article  PubMed  CAS  Google Scholar 

  3. Gardulf A, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R et al (1995) Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 345:365–369

    Article  PubMed  CAS  Google Scholar 

  4. Glöckner WM (1984) Kinetik von Immunglobulin G nach intravenöser und intra-muskulärer Applikation. In: Kornhuber B (ed) Patient-infektion-immunglobulin. Springer, Berlin Heidelberg New York, pp 33–38

    Google Scholar 

  5. Hammarström L, Smith CIE (1990) The use of intravenous IgG as prophylaxis and for treatment of infections. Infection 18:314–324

    Article  PubMed  Google Scholar 

  6. Han S-H, Martin P, Edelstein M, Hu R, Kunder G, Holt C et al (2003) Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation. Liver Transplant 9:182–187

    Article  Google Scholar 

  7. Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H et al (1998) Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 28:585–589

    Article  PubMed  CAS  Google Scholar 

  8. Partovi N, Guy MW, Ensom MHH, Noble MA, Yoshida EM (2001) A study of the pharmacokinetic profile of low-dose hepatitis B immune globulin in long-term liver transplant recipients for chronic hepatitis B infection. Am J Transplant 1:51–54

    Article  CAS  Google Scholar 

  9. Thürmann PA, Sonnenburg-Chatzopoulos C, Lissner R (1995) Pharmacokinetic characteristics and tolerability of a novel intravenous immunoglobulin preparation. Eur J Clin Pharmacol 49:237–247

    Article  PubMed  Google Scholar 

  10. Thürmann PA, Sonnenburg C, Valentova K, Gregora E, Freischläger F, Lissner R (2001) Pharmacokinetics of viral antibodies after administration of intravenous immunoglobulin in patients with chronic lymphocytic leukaemia or multiple myeloma. Eur J Clin Pharmacol 57:235–241

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by Biotest AG, Dreieich, Germany, the manufacturer of the test medication.

Author information

Authors and Affiliations

  1. Philipp Klee-Institute of Clinical Pharmacology, HELIOS Klinikum Wuppertal, University Witten/Herdecke, Heusnerstr. 40, 42283, Wuppertal, Germany

    Petra A. Thürmann, Jacek Szymanski, Steffen Haffner & Ute Tenter

  2. Institute for Research and Development IFE, Essen, Germany

    Frank Grieger

  3. Biotest AG, Dreieich, Germany

    C. Sonnenburg

Authors
  1. Petra A. Thürmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacek Szymanski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steffen Haffner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ute Tenter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Frank Grieger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Sonnenburg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Petra A. Thürmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thürmann, P.A., Szymanski, J., Haffner, S. et al. Pharmacokinetics and safety of a novel anti-HBs-enriched immunoglobulin in healthy volunteers after subcutaneous and intramuscular administration. Eur J Clin Pharmacol 62, 511–512 (2006). https://doi.org/10.1007/s00228-006-0137-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-006-0137-8

Keywords

Search

Navigation